A strong team with experience and know-how

Management

Attila Strauss

 

Kilian Brenske - Vorstand
Kilian Brenske

Kilian Brenske

Mr Kilian Brenske studied business administration in Berlin and graduated with a Master of Science in Management and Innovation.

Mr Kilian Brenske has been with the company since 2016 and has been responsible for all major business areas in Germany and abroad during this time. In particular, he built up the medical skin care brand M1 Select, significantly improved the productivity of the sites and most recently led the international expansion. With the addition of Mr. Kilian Brenske to the Management Board, M1 Kliniken AG is underlining its strategic goal of international growth. Mr Brenske will be responsible for national and international expansion, marketing, purchasing and sales.

 

Board

Uwe Zimdars
Prof. Dr. med. Dirk Hempel
Prof. Dr. Dr. Sabine Meck

Latest news

| Investor News

The Supervisory Board of M1 Kliniken AG today appointed Mr. Attila Strauss to the Management Board of M1 Kliniken AG with immediate effect.

 

| Investor News

At its meeting today, the Supervisory Board of M1 Kliniken AG appointed Mr. Kilian Brenske (28, M.Sc.) to the management board of M1 Kliniken AG.

| Investor News

  • Group turnover decreases to EUR 214 million (EUR 236 million as of Q3-2021)
  • Group EBITDA amounts to EUR 10.9 million (previous year: EUR 12.0 million); EBIT amounts to EUR 6.5 million (previous year: EUR 7.8 million)
  • Beauty: Extension of regional expansion to Eastern Europe with opening of first beauty centre in Budapest/Hungary in September 2022

| Investor News

  • Group revenue falls to just under EUR 139 million (EUR 165 million in H1-2021)
  • Group EBITDA amounts to EUR 7.4 million (previous year: EUR 9.9 million); EBIT amounts to EUR 4.5 million (previous year: EUR 7.1 million)
  • Beauty: Increase in treatment and sales figures; five new centres already opened in 2022; no influence of the deteriorating consumer climate so far